Veteran CDMO executive to guide next phase of global expansion and operational excellence for lentiviral vector manufacturer.

OXB completes acquisition of remaining stake in US subsidiary Progression to full ownership aligns with global strategy and ...

The Hopewell site is equipped to support clinical-stage development, process-development, and scaleup for cell and gene therapy programs.

CSL will consolidate its R&D teams around six sites located in biotech hubs as the company looks to boost external ...

Explore the latest advances in R&D and manufacturing of in vivo lentiviral vectors. Discover the challenges faced in this process and the innovative solutions being developed in the field.

Spanish gene therapy specialist VIVEbiotech has named Patricio Massera as its new president, bringing in a seasoned CDMO ...

About Vector BioMed Vector BioMed is a public benefit corporation redefining lentiviral vector manufacturing for accessible, affordable cell and gene therapies.

Regenerative medicine market accelerates as aging populations and reimbursement shifts raise demand. AI-guided gene editing, ...

EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 70 countries worldwide. For more ...

The 128,000 sq ft GMP facility is purpose-built for manufacturing high-quality plasmid DNA and viral vectors, including adeno-associated virus (AAV) and lentiviral vector (LVV) platforms ...